In the UC-associated dysplasia–carcinoma sequence, p53 gene mutations are early events in 50% of patients with UC compared with approximately 10% of adenomas related to the typical adenoma–carcinoma sequence [34,48]. The gene discussed is TP53; the disease is carcinoma.